Back to News
Market Impact: 0.1
Elite Pharmaceuticals, Inc. Elects Aqeel A. Fatmi and John W. LaRocca to Board of Directors on October 28, 2026
Source: Nasdaq
Management & Governance
On October 28, 2026, Elite Pharmaceuticals’ board unanimously elected Aqeel A. Fatmi, Ph.D., and John W. LaRocca, Esq., as Class II and Class I directors, respectively. The board expanded from four to six directors; the article text is truncated before stating when the appointments take effect.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- ‘Lawyer up’: Democrats take the House, and warn Trump’s family businesses are first in line for subpoenas
- Meta says automation wrongly took down No Kings and a Senate candidate’s page. It’s automating more anyway
- Apple's Happy Holiday Forecast Overshadowed by Shrinking Margin
- Disney plans several thousand layoffs, asks some managers to cut costs by up to 20%
- OpenAI’s hiring of former Army Secretary just 2 months after Pentagon resignation is part of a ‘trend’ of it pivoting resources to defense projects
- Pfizer hikes full-year outlook, taps company veteran as new CFO